Results 151 to 160 of about 43,668,679 (193)

[Human T-lymphotropic virus type 1 uveitis in children].

Nippon Ganka Gakkai zasshi, 1997
We report here five pediatric patients with human T-lymphotropic virus type 1 (HTLV-I) uveitis. The patients were one boy and four girls aged between 3 and 14 years. The transmission route was considered to be breast feeding from their mothers. All patients had unilateral uveitis and the ocular symptoms were similar to those in HTLV-I uveitis in adults.
K, Kihara, M, Tsuruda, A, Ono, E, Ikeda, N, Hikita, N, Miyata, M, Mochizuki   +6 more
openaire   +3 more sources

Mechanisms of human T-lymphotropic virus type 1 transmission and disease

Current Opinion in Virology, 2012
Human T-lymphotrophic virus type-1 (HTLV-1) infects approximately 15-20 million people worldwide, with endemic areas in Japan, the Caribbean, and Africa. The virus is spread through contact with bodily fluids containing infected cells most often from mother to child through breast milk or via blood transfusion.
Michael D, Lairmore, Robyn, Haines, Rajaneesh, Anupam   +2 more
openaire   +2 more sources

Human T‐lymphotropic Virus 1 (HTLV‐1) infection – dermatological implications

International Journal of Dermatology, 2011
AbstractHuman T‐lymphotropic virus type 1 (HTLV‐1) is a type C retrovirus primarily endemic to Japan, Central and South America, the Middle East, regions of Africa, and the Caribbean. Currently, an estimated 10–20 million people worldwide are infected with this virus.
Masahiro, Amano, Mitsuru, Setoyama, Annika, Grant, Francisco A, Kerdel   +3 more
openaire   +2 more sources

Detection of antibodies to human T‐lymphotropic virus type 1 (HTLV‐1)

Transfusion, 1988
Sera from 39,898 blood donors were tested for HTLV‐1 antibodies using two enzyme immunoassays (EIA). Sera testing initially reactive (IR) were retested in duplicate by both EIAs. Sera testing repeatedly reactive (RR) were further tested by two Western blots (WB) and by two radioimmunoprecipitation assays (RIPA).
C T, Fang, A E, Williams, S G, Sandler, D J, Slamon, B J, Poiesz   +4 more
openaire   +2 more sources

Drug Targets in Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection

Infectious Disorders - Drug Targets, 2009
Human T-lymphotropic virus type 1 (HTLV-1), the first known human retrovirus, induces various human diseases with a long latency period. The mechanism by which the virus causes diseases is still unknown. Studies indicate that viral replication is important at least for the development of HTLV-1 associated myelopathy, and therefore treatments based on ...
Péter, Boross, Péter, Bagossi, Irene T, Weber, József, Tözsér   +3 more
openaire   +2 more sources

Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1

AIDS, 2012
HIV-individuals are at risk for human T-lymphotropic virus (HTLV) coinfection and neurological diseases. Little is known about the impact of HAART among coinfected patients. In this study, 47 out of 428 HIV individuals were coinfected with HTLV (10.9%).
Marcus T T, Silva, Elizabeth S, Neves, Beatriz, Grinsztejn, Otávio, de Melo Espíndola, Doris, Schor, Abelardo, Araújo   +5 more
openaire   +2 more sources

Human T‐lymphotropic virus 1 (HTLV‐1) pathogenesis: A systems virology study

Journal of Cellular Biochemistry, 2018
AbstractThe main mechanisms of interaction between Human T‐lymphotropic virus type 1 (HTLV‐1) and its hosts in the manifestation of the related disease including HTLV‐1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and Adult T‐cell leukemia/lymphoma (ATLL) are yet to be determined.
Sayed‐Hamidreza Mozhgani, Mohadeseh Zarei‐Ghobadi, Majid Teymoori‐Rad, Talat Mokhtari‐Azad, Mehdi Mirzaie, Mohsen Sheikhi, Seyed‐Mohammad Jazayeri, Ramin Shahbahrami, Hedayatollah Ghourchian, Mohieddin Jafari, Seyed‐Abdolrahim Rezaee, Mehdi Norouzi   +11 more
openaire   +2 more sources

Micturitional Disturbance in Human T-Lymphotropic Virus Type-1-Associated Myelopathy

Journal of Spinal Disorders, 1994
We reported the findings of micturitional histories and urodynamic studies in five patients with human T-lymphotropic virus type-1-associated myelopathy. Histories showed that all patients had obstructive as well as irritative micturitional symptoms, and four of their micturitional symptoms appeared from the onset of the disease.
T, Hattori, R, Sakakibara, T, Yamanishi, K, Yasuda, K, Hirayama   +4 more
openaire   +2 more sources

Human T-lymphotropic virus-1 serology in the Northern Territory: 2008–2011

Pathology, 2014
A retrospective observational study of human T-lymphotropic virus-1 (HTLV-1) serology requests made to the Northern Territory Government Pathology Service (NTGPS) between 2008 and 2011, was undertaken to review aspects of HTLV-1 sero-epidemiology and performance of the assays.
R, Grivas, K, Freeman, R, Baird
openaire   +2 more sources

Human T-Lymphotropic Virus Type 1 (HTLV-1): Persistence and Immune Control

International Journal of Hematology, 2003
The human retrovirus human T-lymphotropic virus type 1 (HTLV-1) is associated with two distinct types of disease: the malignancy known as adult T-cell leukemia and a range of chronic inflammatory conditions including the central nervous system disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
openaire   +2 more sources